Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial
by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe
Updated on: March 07,2024
15
Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial
by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe
Updated on:March 07,2024
15
